Dermalogica has introduced PRO Pen Microneedling System, its first medical device cleared by the United States Food and Drug Administration, marking a significant milestone as the professional skincare brand dives deeper into advanced aesthetics. Aurelian Lis, CEO of Unilever-owned Dermalogica, characterized the move as both an offensive and defensive investment in the professional channel as consumer-facing devices and minimally invasive treatments are proliferating rapidly.